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Abstract. 
 
Integrin-mediated adhesion to the extracellular
matrix permits efﬁcient growth factor-mediated activation
of extracellular signal–regulated kinases (ERKs). Points
of regulation have been localized to the level of receptor
phosphorylation or to activation of the downstream
components, Raf and MEK (mitogen-activated protein
kinase/ERK kinase). However, it is also well established
that ERK translocation from the cytoplasm to the nu-
cleus is required for G1 phase cell cycle progression.
Here we show that phosphorylation of the nuclear ERK
substrate, Elk-1 at serine 383, is anchorage dependent in
response to growth factor treatment of NIH 3T3 ﬁbro-
blasts. Furthermore, when we activated ERK in non-
adherent cells by expression of active components of
the ERK cascade, subsequent phosphorylation of Elk-1
at serine 383 and Elk-1–mediated transactivation were
still impaired compared with adherent cells. Elk-1
phosphorylation was dependent on an intact actin cy-
toskeleton, as discerned by treatment with cytochalasin
D (CCD). Finally, expression of active MEK failed to
 
predominantly localize ERK to the nucleus in sus-
pended cells or adherent cells treated with CCD. These
data show that integrin-mediated organization of the
actin cytoskeleton regulates localization of activated
ERK, and in turn the ability of ERK to efﬁciently
phosphorylate nuclear substrates.
Key words: integrins • extracellular signal–regulated
kinase • Elk-1 • actin cytoskeleton • translocation
 
Introduction
 
Cells utilize several cytoplasmic mitogen-activated protein
(MAP)
 
1 
 
kinase modules to transduce signals from the extra-
cellular environment to the nucleus, ultimately regulating
cell proliferation, differentiation, and survival decisions.
The extracellular signal–regulated kinase (ERK) family
of MAP kinases is activated by several growth factors via a
pathway that involves GTP-loading of Ras and sequential
phosphorylation and activation of Raf, MEKs (MAP kinase/
ERK kinases), and ERK. Recently it has been shown that ac-
tivation of ERK is also controlled by adhesion via integrins.
Fibroblast cell lines or endothelial cells maintained in
suspension weakly activate ERK when stimulated with
growth factors or G protein receptor agonists compared
with cells that are adherent to matrix proteins or anti-
integrin antibodies (Miyamoto et al., 1996; Lin et al.,
1997; Renshaw et al., 1997; Aplin et al., 1999; Short et al.,
2000). Integrins tether the actin cytoskeleton to the mem-
brane via focal complex/adhesion sites (Calderwood et al.,
2000), and collaborative signaling is dependent on intact
cortical actin structures and/or small focal complexes (Aplin
and Juliano, 1999). Thus, it is likely that integrins utilize the
actin network as a scaffold to enhance growth factor acti-
vation of the ERK pathway.
Upon mitogenic stimulation, ERK translocates from the
cytoplasm to the nucleus, where it phosphorylates the ter-
nary complex factors Elk-1 and Sap-1a (Chen et al., 1992;
Gille et al., 1992; Lenormand et al., 1993). Phosphoryla-
tion of Elk-1 increases its affinity for the serum response
factor and in concert enhances transcription of growth-
related proteins, such as c-Fos (Marais et al., 1993;
Whitmarsh et al., 1995). Several sites in the COOH termi-
nus of Elk-1 are phosphorylated by ERK, the most critical of
which appears to be serine 383 (Marais et al., 1993). ERK-
mediated transcriptional events ultimately impinge on cell
cycle elements, such as the induction of cyclin D1 (Albanese
et al., 1995; Lavoie et al., 1996), although it is becoming evi-
dent that activation of additional pathways, such as the
phosphatidyl-inositol-3-kinase pathway, are often required
for cell cycle progression (Marshall, 1999).
Progression through the G1 phase of the cell cycle is
jointly regulated by adhesion to the extracellular matrix
and circulating growth factors, and is manifested in alter-
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ations in the levels of cyclin D1 and the cyclin-dependent
kinase inhibitors, p21
 
cip1
 
 and p27
 
kip1
 
 (Assoian, 1997; Bot-
tazzi et al., 1999). Integrin–growth factor collaboration
leading to efficient activation of ERK correlates with an-
chorage-dependent effects on cyclin D1 levels (Roovers et
al., 1999). Nonetheless, recent reports provide evidence
that simply activating ERK in the absence of integrin en-
gagement is not always sufficient for cyclin D1 expression.
Thus, Roovers et al. reported that forced activation of
ERK in suspended NIH 3T3 cells substantially overrides
the adhesion requirement for expression of cyclin D1
(Roovers et al., 1999). In contrast, Le Gall et al. (1998)
found that forced ERK activation is not sufficient to in-
duce cyclin D1 and downstream events, such as hyper-
phosphorylation of the retinoblastoma protein and S
phase entry, in suspended CCL 39 fibroblasts. Together,
these data raise the possibility that the regulatory effect of
integrins on the ERK pathway may extend beyond the
level of ERK activation.
ERK translocation to the nucleus is essential for G1
phase progression (Brunet et al., 1999). In resting condi-
tions, ERK is anchored in the cytoplasm by its association
with MEK (Fukuda et al., 1997), the microtubule network
(Reszka et al., 1995), and phosphatases, for example MAP
kinase phosphatase-3 (MKP-3), and the protein tyrosine
phosphatase SL (Camps et al., 1998; Blanco-Aparicio et
al., 1999). MEK–ERK association is disrupted upon mito-
genic stimulation and a proportion of ERK translocates to
the nucleus. The requirement for MAP kinases to move
between the cytoplasmic and nuclear compartments to ful-
fill many of their actions highlights the importance of reg-
ulated movement through nuclear pore complexes. Active
transport between the cytoplasmic and nuclear compart-
ments is a bidirectional process: specific cytoplasmic pro-
teins are imported into the nucleus, and proteins, tRNA,
and mRNAs are exported from the nucleus (Gorlich,
1998; Kaffman and O’Shea, 1999). Identification of a con-
sensus nuclear localization signal (NLS) characterized by
one or more clusters of basic amino acids in numerous
proteins has spurred on the study of the mechanism under-
lying nucleocytoplasmic trafficking. In general, nuclear
import of proteins requires the concerted action of import-
ins 
 
a
 
 and 
 
b
 
 (also known as karyopherins) acting as carrier
molecules, the small GTPase Ran, and pp15 (also known
as p10 or NTF2). However, ERKs do not contain a con-
sensus nuclear localization sequence. Rather, translo-
cation is dependent on phosphorylation of ERK at the
regulatory threonine and tyrosine residues and also on ho-
modimerization (Fukuda et al., 1997; Khokhlatchev et al.,
1998). ERK translocation is likely to be an active mecha-
nism possibly through interactions with the importin pro-
teins that play a key role in protein passage across the nu-
clear membrane (Gorlich, 1998). Once dephosphorylated
in the nucleus, ERK is rapidly exported via an active
mechanism that is mediated, at least in part, by MEK that
has entered the nucleus independently from ERK (Adachi
et al., 2000).
As ERK translocation is a critical determinant in the
transcriptional and biological responses to activation of
this pathway, we addressed whether ERK activity, in the
absence of integrin engagement, was able to impinge on
nuclear events. We demonstrate that under conditions of
 
equivalent ERK activity, ERK-mediated phosphorylation
of the transcription factor Elk-1 is diminished in the ab-
sence of integrin engagement or upon disruption of the ac-
tin cytoskeleton. Additionally, Elk-1–driven gene tran-
scription is low in nonadherent cells despite ERK being
activated. Both during nonadherent conditions and in the
absence of an intact cytoskeleton in adherent cells, ERK
predominantly accumulated in the cytoplasm rather than
translocating to the nucleus. Thus, integrin-mediated ad-
hesion permits ERK to efficiently localize in the nucleus
and phosphorylate a key downstream nuclear substrate.
 
Materials and Methods
 
Plasmids
 
FLAG epitope–tagged Elk-1 in pCMV5 (Yang et al., 1998) was provided
by Dr. A. Sharrocks (University of Manchester, Manchester, England).
The 22W Raf cDNA, a gift from Dr. C. Der (University of North Carolina
at Chapel Hill), was subcloned into pcDNA3.1 (Invitrogen). pMCL-
MEK1-
 
D
 
ED, encoding an active version of MEK1 with an NH
 
2
 
-terminal
deletion of residues 32–51 and serine residues within its activation loop re-
placed with acidic amino acids, was from Dr. N. Ahn (University of Colo-
rado, Boulder, CO) (Mansour et al., 1994).
 
Cell Culture and Transfection
 
NIH 3T3 and Tet-off NIH 3T3 cells were maintained in DMEM contain-
ing 10% bovine calf serum. Additionally, 2 
 
m
 
g/ml tetracycline was in-
cluded in the medium for the Tet-off cell lines as described previously
(Roovers et al., 1999; Zhu et al., 2000). Tet-off NIH 3T3 cells harboring ei-
ther a construct encoding a constitutively active form of MEK1, MEK1-
S218D/S222D, [tet-MEK*-3T3], or cyclin D1 [tet-cyclin D1-3T3] were
used. To retain high percentages of cells expressing active MEK, clones
were used at low (
 
,
 
20) passage numbers. The tet-MEK*-3T3 cell clone
7B was used in these experiments. Transient transfections were performed
with SuperFect (QIAGEN) according to the manufacturer’s instructions.
 
Cell Adhesion and Preparation of Cell Lysate
 
Confluent cells were serum starved and processed as described previously
(Aplin and Juliano, 1999). In brief, cells were detached with trypsin, which
was subsequently quenched with soybean trypsin inhibitor (GIBCO
BRL). Cells were resuspended in DMEM with 1% BSA and incubated
nonadherently at 37
 
8
 
C for 45 min in a rotator. Cells were then plated onto
dishes coated with 10 
 
m
 
g/ml human fibronectin (Collaborative Biomedical
Product) for a further 3 h. As indicated, some cells were treated stimu-
lated with 10–20 ng/ml EGF; no significant differences were seen between
concentrations within this range. Cells were lysed in a modified RIPA
buffer and cell lysates were cleared by centrifugation at 16,000 
 
g
 
.
 
Immunofluorescence Microscopy
 
Cells replated on glass coverslides were prepared for immunofluorescence
microscopy as described previously (Aplin and Juliano, 1999). Elk-1 was
detected with anti–Elk-1 polyclonal antibody (New England Biolabs, Inc.).
Slides were viewed on a ZEISS Axioskop microscope equipped for epiflu-
orescence and images were captured using MetaMorph imaging software.
For confocal microscopy experiments, tet-MEK*-3T3 and tet-cyclin D1-
3T3 cells were incubated in serum-free DMEM for 24 h and subsequently
reseeded onto coverslips for the control monolayer and cytochalasin D
(CCD; 2 
 
m
 
g/ml final concentration)-treated cultures, or into petri dishes
coated with 1% agarose for the suspension cultures. The cells were main-
tained in 10% FCS in the absence of tetracycline for either 6 or 9 h to allow
for efficient expression of ectopic active MEK and cyclin D1. At selected
times spanning G1 phase, control monolayer, CCD, and suspension cul-
tures were fixed and stained as described previously (Zhu et al., 1999).
MEK1 was detected with an anti-MEK1 monoclonal antibody (Transduc-
tion Laboratories), and ERK was detected with an anti-ERK1 polyclonal
antibody (clone K-23; Santa Cruz Biotechnology, Inc.). The immunofluo-
rescence analysis for cyclin D1 was performed using the ammonium sulfate
fraction of a polyclonal cyclin D1 antibody prepared against recombinant 
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murine cyclin D1. Slides were visualized using a Leica TCS 4D confocal
immunofluorescence microscope and 1-
 
m
 
m sections were captured at 40
 
3
 
magnification using an Image Graphics image recorder.
 
Immunoprecipitation, Western Blotting, and
Kinase Reactions
 
Immunoprecipitations were performed either overnight or for 2 h at 4
 
8
 
C
from precleared lysates followed by a further incubation with protein
G-Sepharose for 2 h at 4
 
8
 
C. FLAG–Elk-1, endogenous focal adhesion ki-
nase (FAK), and hemagglutinin (HA)-ERK1 were immunoprecipitated
with anti-FLAG antibody (Sigma-Aldrich), clone 2A7 (Upstate Biotech-
nology), and anti-HA antibody, 12CA5 (Babco), respectively. Precipitates
were washed three times with cold RIPA buffer, and boiled with SDS-
PAGE sample buffer to dissociate the proteins. For analysis by Western
blotting, samples were separated by SDS-PAGE under reducing condi-
tions. Phosphoserine 383 and total levels of Elk-1 were detected using an-
tibodies from New England Biolabs, Inc. and Santa Cruz Biotechnology,
Inc. Antibodies to the Raf COOH terminus (clone C-12; Santa Cruz Bio-
technology, Inc.), FAK (clone 77, Transduction Laboratories), MEK
(Transduction Laboratories), dually phosphorylated ERK (New England
Biolabs, Inc.), total ERK (Santa Cruz Biotechnology, Inc.), and phospho-
tyrosine (clone 4G10; Upstate Biotechnology) were also used. Immunore-
activity was detected using horseradish peroxidase–conjugated secondary
antibodies and enhanced chemiluminescence. HA-ERK1 in vitro kinase
assays using myelin basic protein as substrate have also been described
previously (Aplin and Juliano, 1999).
 
Luciferase Reporter Assays
 
Elk-1 transcriptional activity was determined using a construct encoding a
fusion between the GAL4 DNA binding domain and the transactivation
domain of Elk-1 (GAL4–Elk-1). NIH 3T3 cells were transfected with 500
ng GAL4–Elk-1, 500 ng of a reporter plasmid controlling the transcription
 
of firefly luciferase (pFR-luc), 10 ng of pRL-CMV-luc (
 
Renilla
 
 luciferase
under the control of the CMV promoter), and 1 
 
m
 
g of either pcDNA3-22W
Raf or empty vector. Cells were transfected for 4 h, serum starved for 8 h,
and then detached from the dish and rolled for 45 min in DMEM/BSA.
The subsequent increase in luciferase activity was determined in cells ei-
ther maintained in suspension or replated on fibronectin for a further 4 h.
Luciferase activities were determined using the dual luciferase assay kit
(Promega). Cells were extracted and assayed sequentially for firefly and
 
Renilla 
 
luciferase activities. Cell lysate (20 
 
m
 
l) was incubated with 100 
 
m
 
l
of luciferin reagent and luminescence recorded for 10 s in an Analytical
Luminescence Laboratory Monolight 2010 luminometer. Subsequently,
Stop and Glo
 
®
 
 reagent (100 
 
m
 
l) was added and the specific luminescence
from the 
 
Renilla 
 
luciferase was recorded for an additional 10 s. Firefly ac-
tivities were normalized to 
 
Renilla
 
 luciferase activity.
 
Results
 
Growth Factor–mediated Phosphorylation of Elk-1 at 
Serine 383 Is Adhesion Dependent
 
Activation of ERK by growth factors in human and mouse
fibroblasts is dependent on the state of adhesion (Miya-
moto et al., 1996; Lin et al., 1997; Renshaw et al., 1997;
Aplin and Juliano, 1999). The transcription factor Elk-1 is
a substrate for ERK, and phosphorylation at several
COOH-terminal sites, including serine 383, is critical for
its transcriptional potential (Marais et al., 1993; Whit-
marsh et al., 1995). We initially determined whether Elk-1
displays anchorage-dependent phosphorylation in re-
sponse to growth factors. NIH 3T3 fibroblasts express low
levels of endogenous Elk-1, hence we used transient trans-
Figure 1. Adhesion to fibronectin
and EGF collaborate to provide
efficient phosphorylation of the
Elk-1 transcription factor. NIH
3T3 cells were transfected with
either  pCMV5 (Vector) or
pCMV5-FLAG-Elk-1. In A, 1 mg
of green fluorescent protein
(GFP) was included in the trans-
fections to identify transfected
cells. After 48 h, transfected cells
were serum starved before being
replated in DMEM/BSA on fi-
bronectin-coated coverslips (A) or
maintained in suspension (Sus) or
replated on fibronectin (Fn)-coated
dishes for a further 3 h (B). (A)
Localization of Elk-1 was deter-
mined by immunofluorescence
with an Elk-1 antibody and
TRITC-conjugated anti–rabbit
secondary antibody. The scale bar
depicts a 10 micron distance. (B)
After the 3-h incubation, cells
were treated with 20 ng/ml EGF
for 15 min as indicated. Ectopically
expressed Elk-1 was immunopre-
cipitated (IP) from cell lysates from
each condition with an M2 FLAG
epitope antibody. Immunoprecipi-
tates were analyzed by Western
blotting (WB) with antibodies to
determine phosphorylated and
total Elk-1 levels.  
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fection of a FLAG-tagged version of Elk-1 which localized
to the nucleus as determined by immunofluorescence.
Identical results were obtained with antibodies to Elk-1
(Fig. 1 A) and the FLAG epitope (data not shown). The
phosphorylation status of Elk-1 was monitored by immu-
noprecipitation followed by Western blotting with a serine
383 phosphorylation state–dependent antibody. When
transfected cells adherent to fibronectin were stimulated
with EGF, Elk-1 was robustly phosphorylated at serine
383 (Fig. 1 B). In contrast, Elk-1 was weakly phosphory-
lated upon EGF treatment in nonadherent cells. Thus,
Elk-1 phosphorylation is adhesion dependent in response
to growth factors in a manner that closely correlates with
adhesion effects on ERK activation (Lin et al., 1997; Aplin
and Juliano, 1999).
 
Expression of Active Raf or MEK1 Renders ERK 
Activity Adhesion Independent
 
Next we sought to determine whether restoring the ability
of cells to activate ERK, while maintained in suspension,
was able to impinge on nuclear events by phosphorylating
Elk-1. To this end we used an active mutant of Raf, known
as 22W Raf, that has an NH
 
2
 
-terminal deletion of 305
amino acids and high transforming potential (Stanton and
Cooper, 1987). 22W Raf was expressed as a 36-kD protein
in NIH 3T3 cells that was recognized by a COOH-terminal
Raf antibody (Fig. 2 A). Whereas activation of an epitope-
tagged version of ERK1 (HA-ERK1) was anchorage de-
pendent in response to growth factor, expression of 22W
Raf led to a robust activation of HA-ERK1 in cells either
maintained in suspension or adherent to fibronectin (Fig. 2
B). Importantly, the activation of HA-ERK1 was equiva-
lent in cells under these conditions at this 3-h time point
(Fig. 2 B) and throughout a 2–6-h time period (Fig. 2 C).
Additionally, we used a constitutively active version of
MEK1, referred to as MEK1-
 
D
 
ED. Akin to 22WRaf, ex-
pression of MEK1-
 
D
 
ED efficiently activated ERK1 re-
gardless of the cellular state of adhesion (Fig. 2 D). Acti-
vation of the c-Jun NH2-terminal kinase (JNK) pathway
also results in phosphorylation of Elk-1 (Whitmarsh et al.,
1995). As expected, expression of 22W Raf or MEK1-
 
D
 
ED did not result in activation of an epitope-tagged ver-
sion of JNK1 (data not shown). Together, these data show
that the adhesion-dependent requirement for the activa-
tion of ERK is bypassed by expression of active versions
of Raf and MEK.
 
Active ERK Requires Adhesion-dependent Signals to 
Efficiently Phosphorylate Elk-1
 
To examine whether active ERK was able to phosphory-
late Elk-1 at serine 383 in the absence of integrin engage-
ment, we cotransfected cells with Elk-1 and either 22W
Raf or empty vector. As before, control transfected cells
exhibited little phosphorylation of Elk-1 when either held
in suspension or readhered to fibronectin for 3 h in the ab-
sence of growth factors (Fig. 3 A). Expression of 22W Raf
stimulated ERK phosphorylation of Elk-1 at serine 383 in
adherent cells, but this effect was markedly reduced under
suspension conditions (Fig. 3 A). The levels of Elk-1 and
22W Raf were comparable between the suspension and fi-
bronectin conditions (Fig. 3 A, and latter data not shown).
Similarly, expression of MEK1-
 
D
 
ED resulted in efficient
phosphorylation of serine 383 in Elk-1 when cells were ad-
herent to fibronectin but not under suspension conditions
(Fig. 3 B). In both the 22W Raf and MEK1-
 
D
 
ED experi-
ments, there remained a small but noticeable increase in
the phosphorylation of Elk-1 above control conditions in
suspended cells. Thus, the adhesion effect on ERK-medi-
ated phosphorylation of Elk-1 is potent but not complete.
To address the effect on activation of a reporter
driven by Elk-1, we cotransfected cells with either
empty vector or 22W Raf cDNA, in addition to the
Figure 2. Expression of active Raf
or MEK in suspended cells is suffi-
cient to activate ERK activity. (A)
NIH 3T3 cells transfected either
with pcDNA3 vector (Vec) or
pcDNA3-22W Raf were analyzed
by Western blotting (WB) with the
anti-Raf COOH-terminal (C-term)
antibody, C12, 48 h after transfec-
tion. (B) Cells transfected with
HA-ERK1 and either vector (Vec)
or 22W Raf were replated onto fi-
bronectin (Fn) or maintained in
suspension (Sus) for 3 h, as above.
Some cells were then treated with
10 ng/ml EGF for 5 min as indicated.
HA-ERK was immunoprecipitated
(IP) from cell lysates and assayed
for activity by in vitro kinase assay
using myelin basic protein (MBP) as
a substrate. (C) HA-ERK activity
was measured in vector and 22W
Raf–expressing cells either under
nonadherent or adherent conditions
at several time points. Values were normalized to the activity of HA-ERK at the 2 h time point on Fn. Shown is the mean and standard
deviation of three independent experiments. (D) Cells were cotransfected with equivalent levels of HA-ERK1 and MEK1-DED. HA-
ERK activity was analyzed, as above, in cells maintained in DMEM/BSA in suspension and adherent conditions for 3 h. 
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GAL4–Elk-1 fusion and firefly luciferase reporter con-
structs. GAL4–Elk-1 activity was low in vector-trans-
fected cells either maintained in suspension or replated
onto fibronectin during a 4-h time period (Fig. 3 C). Ex-
pression of 22W Raf enhanced GAL4–Elk-1 activity.
However, 22W Raf–expressing cells maintained in sus-
pension showed only a 2-fold increase over vector-trans-
fected cells compared with a 4.5-fold increase under
adherent conditions (Fig. 3 C). Similarly, GAL4–Elk-1
activity was impaired in 22W Raf–expressing cells treated
with CCD (data not shown). These findings demonstrate
that, under conditions whereby ERK activation is equiva-
lent, Elk-1 transactivation is strongly enhanced under ad-
herent conditions.
 
Disruption of the Actin Cytoskeleton Inhibits ERK 
Phosphorylation of Elk-1
 
Integrin signaling events are typically dependent on an in-
tact actin cytoskeleton. We used the actin depolymerizing
agent, CCD, that caps the ends of growing actin fibers and
inhibits integrin-mediated tyrosine phosphorylation of fo-
cal adhesion proteins (Burridge et al., 1992). Treatment of
22W Raf–expressing cells with CCD significantly reduced
ERK phosphorylation of Elk-1 in adherent cells (Fig. 4 A,
top). Under these conditions, cells remained round but
firmly attached when viewed by microscopy, and FAK
phosphotyrosine levels were dramatically reduced (Fig. 4
A, bottom). Overall, in these transient transfection experi-
ments, the CCD effect was not quite as dramatic as the in-
hibition of Elk-1 phosphorylation in suspension. In vitro
kinase assays demonstrated that ERK activation by 22W
Raf was not inhibited by treatment with CCD (Fig. 4 B).
In contrast, treatment of 22W Raf–expressing cells with
the microtubule-disrupting agent, colchicine, did not in-
hibit Elk-1 phosphorylation at serine 383 (Fig. 4 C). Thus,
the ability of ERK, once activated, to phosphorylate Elk-1
is dependent on an intact actin cytoskeleton, but not the
microtubule network.
Figure 3. Phosphorylation and transcriptional activity of Elk-1
mediated by activated ERK are impaired in nonadherent cells.
NIH 3T3 cells were transfected with FLAG–Elk-1 and either
vector (Vec), 22W Raf (A), or MEK1-DED (B). Serum-starved
cells were either replated on fibronectin-coated plates (Fn) or
maintained in suspension (Sus) for 3 h. FLAG-Elk-1 immunopre-
cipitates (IP) were analyzed by Western blotting (WB) for levels
of serine 383 phosphorylated and total Elk-1. Shown are represen-
tatives of at least three independent experiments with equivalent
results. In C, cells were transfected with GAL4–Elk-1, pFR-luc
reporter, and either vector or 22W Raf. After a brief serum
starvation, cells were replated as above on fibronectin-coated
plates (Fn) or maintained in suspension (Sus). The increase in
GAL4-Elk-1 transactivation of pFR-luc during a 4-h time period
was determined by assaying for firefly luciferase activity. For
each experiment, three separate samples were assayed for each
condition and all readings were normalized to the activity of Renilla
luciferase under the control of a constitutively active CMV pro-
moter (pRL-CMV-luc). The enhanced GAL4–Elk-1–driven lu-
ciferase activity in 22W Raf–expressing cells in adherent compared
with suspended cells is statistically significant (*P , 0.05).
Figure 4. Disruption of the actin cytoskeleton, but not the microtu-
bule network, inhibits the ability of activated ERK to phosphorylate
Elk-1. NIH 3T3 cells were transfected either with vector (Vec) or
22W Raf and either FLAG-Elk-1 (A and C) or HA-ERK1 (B). In A
and B, cells were treated accordingly with 2 mM CCD throughout
adhesion to fibronectin-coated plates (Fn). In C, serum-starved
cells were treated with 50 mM colchicine (Colc), as indicated, before
replating either on fibronectin-coated plates (Fn) or maintained
in suspension (Sus) for 3 h. FLAG-Elk-1 immunoprecipitates
(IP) were analyzed by Western blotting (WB) for levels of
serine 383 phosphorylated and total Elk-1 (A and C). Addition-
ally, in A (bottom) endogenous FAK was immunoprecipitated
from cell lysates and blotted for tyrosine phosphorylation (PY)
and total levels of FAK. In B, HA-ERK was immunoprecipitated
and activity measured by in vitro kinase assay. Shown are rep-
resentatives of at least three independent experiments with
equivalent results. 
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Nuclear Accumulation of ERK Is Impaired by 
Disruption of the Actin Cytoskeleton
 
The above findings suggested that ERK might be unable
to redistribute properly to the nucleus upon activation in
nonadherent conditions. To investigate this possibility, we
used an NIH 3T3 cell line that expresses active MEK1
(tet-MEK*-3T3) under inducible control. Upon induction
of active MEK in these cells, ERK is activated similarly
under adherent and suspension conditions (Roovers et al.,
1999). We used this system to analyze the role of adhesion
upon the localization of ERK, after induction of active
MEK. By confocal analysis, we determined that in adher-
ent tet-MEK*-3T3 cells, ERK was localized primarily in
the nuclear compartment, whereas MEK was present in
the cytoplasm (Fig. 5 A, left). In contrast, in nonadherent
cells, ERK extensively colocalized with MEK in the cyto-
plasmic compartment (Fig. 5 A, right). Higher magnifica-
tion images confirmed that ERK was inefficiently translo-
cated to the nucleus in nonadherent conditions (Fig. 5 B).
Consistent with a role for integrin-associated actin struc-
tures playing an important role, ERK was poorly localized
to the nucleus in adherent tet-MEK*-3T3 cells treated
with CCD (Fig. 5 B). Quantification of 
 
.
 
50 MEK-positive
cells revealed that nuclear ERK staining was predominant
in 75% of adherent cells, but only in 20 and 35% of cells
treated with CCD and incubated in suspension, respec-
tively. Moreover, some suspended and CCD-treated cells
showed diffuse, rather than cytoplasm-specific, ERK
staining. Similar observations on the immunolocalization
of ERK were found in cells transiently expressing 22W
Raf, in that ERK poorly distributed to the nucleus in non-
adherent conditions (data not shown). The confocal analy-
sis agrees well with our Elk-1 results which indicate that
adhesion-dependent translocation of ERK in NIH 3T3
cells is potent but not complete.
We next examined whether the inability of ERK to ac-
cumulate in the nucleus of nonadherent tet-MEK*-3T3
cells, induced to express active MEK, corresponded to in-
efficient phosphorylation of a nuclear target. To this end
we transfected these cells with FLAG–Elk-1 and induced
expression of active MEK in suspension or adherent
conditions. Consistent with earlier published findings
(Roovers et al., 1999), induction of active MEK (by re-
Figure 5. Nuclear accumulation of ERK is im-
paired in nonadherent cells and by disruption of
the actin cytoskeleton. Tet-Mek*-3T3 cells were
serum starved and stimulated with 10% FCS in the
absence of tetracycline for 6–9 h. The localization
of active MEK and ERK was compared in adherent
(Adh) and nonadherent (Sus) cells or adherent
untreated (Adh) vs. CCD-treated (Adh/CCD)
monolayers via confocal microscopy. Bottom pan-
els are of (A) overlays of the MEK and ERK
images or (B) images showing DAPI staining of nuclei. Scale bars represent either a 10 or 5 micron distance, as indicated. (C and
D) tet-MEK*-3T3 cells were transfected with FLAG–Elk-1 as before. Cells were serum starved overnight, after which in some
populations tetracycline was removed from the media to induce expression of active MEK. Cells were detached and either maintained
in suspension (Sus) or replated onto fibronectin (Fn) and lysed 6 h after induction. (C) Levels of MEK expression and activation of
ERK determined by Western blotting (WB) of whole cell lysates. (D) FLAG–Elk-1 was immunoprecipitated (IP) and analyzed by
Western blotting for phosphorylated and total levels of Elk-1. 
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moval of tetracycline from the culture media) was inde-
pendent of anchorage (Fig. 5 C, top). Western blotting
with an antibody that recognizes dually phosphorylated
ERK demonstrated that ERK was phosphorylated to
comparable levels upon removal of tetracycline in both
suspended and adherent cells (Fig. 5 C, middle and bot-
tom). The level of Elk-1 phosphorylation at serine 383 in
uninduced cells was higher than observed in the vector
controls in the transient transfection experiments. This is
likely due to the slightly elevated levels of active ERK in
the noninduced cells. Nevertheless, Elk-1 phosphorylation
was noticeably and consistently increased in adherent, but
not suspension, cells that were induced to express active
MEK (Fig. 5 D). Taken together, data from these confocal
immunolocalization and Elk-1 phosphorylation experi-
ments indicate that despite being active, ERK requires a
state of cellular adhesion for efficient nuclear transloca-
tion, and that integrin–cytoskeletal connections are impor-
tant for this process.
 
Disruption of the Actin Cytoskeleton Does Not Prevent 
Nuclear Accumulation of Cyclin D1
 
Similar to ERK, cyclin D1 does not contain a consensus
nuclear localization sequence; rather, it is localized to the
nucleus via such sequences in the cyclin-dependent kinase
inhibitors, p21
 
cip1
 
 and p27
 
kip1
 
 (LaBaer et al., 1997; Cheng et
al., 1999). To examine the possibility that disruption of the
actin cytoskeleton has a global effect on nucleocytoplasmic
transport, we analyzed nuclear localization of cyclin D1 in
CCD-treated cells. Confocal immunolocalization experi-
 
ments showed that nuclear accumulation of ectopically
expressed cyclin D1 in tet-cyclin D1-3T3 cells, was not
altered upon disruption of the actin cytoskeleton as indi-
cated by its colocalization with DAPI-stained nuclei (Fig.
6). Thus, nuclear accumulation of cyclin D1 protein via a
consensus nuclear signal import mechanism is not depen-
dent on an intact actin cytoskeleton.
 
Discussion
 
Cellular adhesion via integrin receptors is intimately in-
volved with regulation of signaling cascades. Phosphoryla-
tion of the Elk-1 transcription factor in response to growth
factor treatment is impaired in nonadherent conditions.
Under these conditions, growth factor activation of ERK
is impaired. However, in these studies we bypassed this regu-
latory step by expression of active forms of Raf and MEK.
Despite being able to render ERK activity anchorage inde-
pendent, Elk-1 phosphorylation continued to display an
adhesion requirement. Furthermore, we showed by confo-
cal microscopy that when the ERK pathway is activated,
nuclear translocation of ERK is hindered in suspended
cells. Both localization of ERK from the cytoplasm into
the nucleus and phosphorylation of Elk-1 were inhibited
on CCD treatment, highlighting the importance of the in-
tegrin–actin cytoskeletal connection. By contrast, treat-
ment with colchicine failed to abrogate 22W Raf–mediated
phosphorylation of Elk-1, arguing against a requirement
for an intact microtubule network in ERK translocation.
Nuclear localization of ectopically expressed cyclin D1 was
Figure 6. Targeting of cyclin D1 to the
nucleus in not affected by disruption of
the actin cytoskeleton. Tet-cyclin D1-3T3
cells were G0-synchronized and stimulated
with 10% FCS in the absence of tetracy-
cline in monolayer in the absence and
presence of CCD. The cells were fixed 6 h
after stimulation, stained with anti-cyclin
D1 antibody and DAPI nuclear stain, and
analyzed via confocal microscopy. An
overlay of the cyclin D1 and DAPI images
is shown. The scale bars show a 10 micron
distance. Adh, adherent. 
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unaltered by disruption of the actin cytoskeleton, indicat-
ing that interference with nuclear localization is not a gen-
eralized effect. Thus, in addition to integrins being able to
regulate growth factor activation of ERK, we suggest the
presence of a second integrin-regulated checkpoint in the
ERK cascade. This checkpoint is downstream of activa-
tion, but occurs at the level of active ERK accumulation in
the nucleus and phosphorylation of its nuclear substrates.
The observation that integrity of the actin cytoskeleton
is necessary for trafficking of ERK to the nucleus is a
novel and interesting finding. Although it is well estab-
lished that activation of the ERK pathway contributes to
induction of cyclin D1, previous studies have yielded in-
consistent results with regard to the role of ERK signaling
in the adhesion-dependent expression of cyclin D1 expres-
sion. Roovers et al. (1999) reported that forced activation
of the MEK/ERK pathway leads to the expression of cy-
clin D1 in suspended 3T3 cells, whereas Le Gall et al.
(1998), using a similar approach, failed to see cyclin D1 ex-
pression when the MEK/ERK pathway was activated in
suspended CCL39 cells. As relatively low levels of ERK
signaling are sufficient to induce cyclin D1 (for a review
see Roovers and Assoian, 2000), our results may provide
an explanation for these discrepant observations. Perhaps
the different results obtained by Roovers et al. (1999) and
Le Gall et al. (1998) reflects the fact that ERK transloca-
tion to the nucleus is strongly dependent on integrin sig-
naling in some cell lines, whereas it is less strictly depen-
dent on integrin signaling in others. Indeed, we do see low
levels of nuclear ERK staining when induced tet-MEK*-
3T3 cells used in Roovers et al. (1999) are cultured in sus-
pension or treated with CCD.
We favor the explanation that integrins support efficient
ERK translocation to the nucleus, as we find that in cells
expressing active MEK, ERK preferentially colocalizes
with MEK in the cytoplasm of nonadherent but not adher-
ent cells. Other recent findings have pointed towards an
adhesion dependence of ERK translocation to the nucleus
(Danilkovitch et al., 2000). In these studies, macrophage-
stimulating protein showed reduced ERK activation and a
further lack of detectable ERK translocation to the nu-
cleus in suspended RE7 epithelial cells; however, this
study did not examine ERK translocation under condi-
tions where high ERK activity is maintained in suspended
cells. ERK is deactivated by the activity of a variety of cel-
lular phosphatases, including MKPs, and dephosphoryla-
tion of nuclear ERK leads to its rapid export (Khokh-
latchev et al., 1998), thus possibly presenting an alternative
explanation of our results. However, in our system it is un-
likely that dephosphorylation of ERK is upregulated in
suspended cells, as ERK activation mediated by active
versions of either Raf or MEK was unaltered in suspen-
sion versus adherent conditions. Additionally, under se-
rum-free conditions levels of the nuclear-localized MKP-2
are unaltered in suspended versus adherent cells (data not
shown). The activities controlling Elk-1 dephosphoryla-
tion are not well characterized, although recent studies in
COS cells have implicated a role for the calcium-depen-
dent protein phosphatase 2B (calcineurin) (Sugimoto et
al., 1997; Tian and Karin, 1999).
Integrin-mediated adhesion has been shown to recruit a
variety of structural and signaling molecules into special-
ized sites and to cause the membrane localization of the
GTPase, Rac (Burridge et al., 1992; del Pozo et al., 2000).
However, the mechanism underlying effects of adhesion
on ERK trafficking to the nucleus is as yet undetermined.
ERK is sequestered in the cytoplasm through its interac-
tion with binding partners, such as its upstream activator
MEK, and efficient ERK-mediated activation of gene
transcription is enhanced through the binding of the scaf-
folding protein, MEK partner 1 (MP-1) (Schaeffer et al.,
1998). Thus, the balance of ERK interactions between its
upstream activators and scaffolding proteins may be al-
tered by the state of cellular adhesion. Nuclear transloca-
tion of ERK is dependent on its ability to homodimerize;
ERK mutants defective in this ability poorly translocate
to the nucleus when microinjected into fibroblasts
(Khokhlatchev et al., 1998). An intriguing notion is that in-
tegrins, via the formation of an actin-based platform, en-
hance the ability of ERK monomers to homodimerize.
Consistent with this idea, recent evidence suggests, at least
under in vitro conditions, that ERK can directly bind to
actin and actin-binding proteins, such as 
 
a
 
-actinin (Lein-
weber et al., 1999). Furthermore, active ERK molecules
can be detected at sites of integrin-mediated adhesion
(Fincham et al., 2000). Future research will be directed at
understanding the mechanism underlying the adhesion
regulation of ERK nucleocytoplasmic trafficking.
Our findings add credence to the emerging theme that
cell adhesion molecules regulate nuclear signaling events.
Ingber and colleagues have shown that integrin “hard-wir-
ing” is able to impact on nuclear structure (Maniotis et al.,
1997). Further, certain integrins may provide direct modu-
lation of nuclear events. For example, engagement of the
leukocyte integrin LFA-1/
 
a
 
L
 
b
 
2 has been shown to ini-
tially bind and subsequently promote the nuclear localiza-
tion of the c-Jun coactivator, JAB1, leading to enhanced
activating protein 1 (AP-1) transcriptional activity (Bian-
chi et al., 2000). High expression levels of the cell–cell ad-
hesion molecules, E- and N-cadherin, reduce the nuclear
localization and transcription potential of 
 
b
 
-catenin, by re-
cruiting it to sites of cell–cell contact (Sadot et al., 1998;
Orsulic et al., 1999). In conjunction with our current find-
ings on integrin regulation of ERK localization, these
other reports highlight an important role for cell adhesion
molecules and the actin cytoskeleton in the nuclear traf-
ficking of signaling molecules.
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